ST. LOUIS--(BUSINESS WIRE)--
Belden Inc. (NYSE: BDC) announced today that its Board of Directors has
authorized the redemption of all outstanding preferred share purchase
rights issued pursuant to its existing Rights Agreement (commonly known
as a “poison pill”), effective as of the close of business on March 27,
2018. Under the Rights Agreement, one right currently is attached to
each outstanding share of common stock. The rights will be redeemed at a
redemption price of $0.01 per right, payable in cash. The redemption
payment will be payable on April 6, 2018 to the holders of the rights as
of the close of business on March 27, 2018. Rights holders do not have
to take any action to receive the redemption payment and do not have to
exchange stock certificates.
About Belden
Belden produces and sells a comprehensive portfolio of connectivity and
networking products into a variety of markets, including industrial,
enterprise, and broadcast. To obtain additional information, call
Investor Relations at (314) 854-8054, email Investor Relations at investor.relations@belden.com,
or visit Belden’s website at www.belden.com.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20180323005566/en/
Belden Inc.
Investor Relations
314-854-8054
investor.relations@belden.com
Source: Belden Inc.